Mega Ezetimibe Tablet 10 mg (Ezetimibe)

Adult dosage

The recommended dose of this drug is 10 mg once a day, administered regardless of meals. When used in combination with HMG-CoA reductase inhibitors, administration should begin at the recommended starting dose of the HMG-CoA reductase inhibitor along with this drug; when already receiving a high dose of HMG-CoA reductase inhibitors, it should be used in conjunction with maintenance of the HMG-CoA reductase inhibitor dose.

This drug should not be used in patients with hypersensitivity to specific components. Patients with active liver disease or persistently elevated liver enzymes in blood tests should avoid combination therapy with this drug and other specific lipid-lowering agents. The use of this drug and specific lipid-lowering agents is prohibited in pregnant or nursing women, so women of childbearing potential should take caution. The use of this drug is not recommended in patients with moderate to severe liver dysfunction. Although this drug is generally safe, side effects such as headache, abdominal pain, diarrhea, fatigue, and muscle pain may occur; therefore, medical consultation should be sought in case of abnormal symptoms. If symptoms such as muscle pain or weakness occur, medical personnel should be informed immediately, and discontinuation of therapy may be necessary. Patients with severe kidney impairment should also take caution, and renal function should be regularly monitored during administration. This drug may interact with other medications, so it is essential to inform the doctor or pharmacist of any ongoing medications. Pregnant or nursing mothers should carefully consider the potential risks and benefits of using this drug. It is recommended for use in children aged 6 years and older, and it is best not to use it in children under 6 years. Elderly patients can use it safely, but some elderly individuals may be more sensitive to the drug, requiring caution. No specific treatment is available for overdose, but appropriate treatment should be provided based on symptoms. This drug should be kept out of the reach of children and should not be transferred to other containers.

Serious side effects

Urticaria, angioedema, anaphylaxis, rash, hepatitis, pancreatitis, thrombocytopenia, cholelithiasis, cholecystitis, renal failure, liver dysfunction, persistent elevation of liver enzymes (more than three times the normal upper limit), myopathy, rhabdomyolysis, severe allergic reactions, severe skin adverse reactions, respiratory problems, liver abnormalities (jaundice), severe neurological symptoms, severe edema or urination abnormalities

Mild side effects

• Headache
• abdominal pain
• diarrhea
• fatigue
• constipation
• nausea
• muscle pain
• joint pain
• back pain
• dizziness

This drug is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, to maintain the drug's effectiveness, it is best to store it at room temperature between 1 and 30 degrees Celsius.

Appearance

White to off-white oblong tablet

Package unit

10 tablets/box [10 tablets/PTP X 1], 30 tablets/box [10 tablets/PTP X 3], 100 tablets/bottle